Basilea Pharmaceutica AG (BPMUF)
76.25
-1.15
(-1.49%)
USD |
OTCM |
Oct 02, 16:00
Basilea Pharmaceutica Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 34.09B |
| AC Immune SA | 159.91M |
| CRISPR Therapeutics AG | 3.777B |
| Idorsia Ltd. | 2.970B |
Enterprise Value Related Metrics
| Earnings Yield | 6.45% |
| Operating Earnings Yield | 7.14% |
| Normalized Earnings Yield | 6.453 |